Tuesday Nov 14, 2017 - 01:00pm to 02:00pm EST
Event Description: 

In this webinar, the Centers for Disease Control and Prevention (CDC) will present an overview of the opioid overdose epidemic and its public health burden, followed by a description of the multifaceted public health approach.

Drug overdose deaths and opioid-involved deaths continue to increase in the United States. From 2000 to 2015, more than half a million people died from drug overdoses. The majority of drug overdose deaths (more than 6 out of 10) involve an opioid. Since 1999, the number of overdose deaths involving opioids, including prescription opioids and heroin, have quadrupled, and currently 91 Americans die every day from an opioid overdose. We now know that overdoses from prescription opioids are a driving factor in the 15-year increase in opioid overdose deaths. While the amount of prescription opioids sold to pharmacies, hospitals, and doctors’ offices has significantly increased, the amount of pain that Americans report has not. 

From 2002 to 2013, past month heroin use, past year heroin use, and heroin addiction have all increased among 18- to 25-year-olds. The number of people who started to use heroin in the past year is also trending up. Among new heroin users, approximately three out of four report misusing prescription opioids prior to using heroin. The increased availability, lower price, and increased purity of heroin in the United States have been identified as possible contributors to rising rates of heroin use.  According to data from the Drug Enforcement Administration, the amount of heroin seized each year at the southwest border of the United States was approximately 500 kg during 2000–2008. This amount quadrupled to 2,196 kg in 2013. Heroin-related deaths more than tripled between 2010 and 2015, with 12,989 heroin deaths in 2015. The largest increase in overdose deaths from 2014 to 2015 was for those involving synthetic opioids (other than methadone), which rose from 5,544 deaths in 2014 to 9,580 deaths in 2015. One of these synthetic opioids, illicitly manufactured fentanyl, drove the increase. Illicit fentanyl is often mixed with heroin and/or cocaine as a combination product – with or without the user’s knowledge.

This presentation will provide an overview of the CDC response to this growing and evolving opioid epidemic. The CDC response is based on three main pillars: improving the prescribing of opioids, expanding the availability of treatment for addiction, and reducing access to illicit opioids. Some of the key activities to be described include:

  • Using the CDC Guideline for Prescribing Opioids for Chronic Pain to improve opioid prescribing to reduce exposure to opioids and prevent opioid use disorder and overdose.
  • Expanding access to evidence-based substance abuse treatment, such as Medication-Assisted Treatment, for people already struggling with opioid addiction.
  • Expanding access and use of naloxone – a safe antidote to reverse opioid overdose.
  • Promoting the use of state prescription drug monitoring programs (PDMPs), which give healthcare providers information to improve patient safety. States have implemented a range of ways to make PDMPs easier to use and access, and these changes have significant potential for ensuring that the utility and promise of PDMPs are realized.
  • Implementing and strengthening strategies in health systems that help prevent high-risk prescribing and prevent opioid overdose.
  • Improving detection of the trends of illicit opioid use by working with state and local public health agencies, medical examiners and coroners, and law enforcement.

Learning Objectives:

  1. Describe the evolving nature of the opioid overdose epidemic in terms of the role of prescription opioids, heroin, and illicitly manufactured synthetic opioids.
  2. Describe the main tenets of the CDC Guideline for Prescribing Opioids for Chronic Pain.
  3. Describe available clinical, educational, and media campaign tools to aid in opioid overdose prevention.

Funding for this webinar has been brought to you by the National Institute of Justice’s Forensic Technology Center for Excellence.

Organizer Information
Event Organization: 
National Institute of Justice
Program Areas: 
Groups audience: 
- Private group -